Skip to main content
Ezra Rosen, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

EzraRosenMD

Oncology New York, NY

Physician

Overview of Dr. Rosen

Dr. Ezra Rosen is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice 9 years. He is one of 464 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 10 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2013 - 2016
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2013

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • NJ State Medical License
    NJ State Medical License 2020 - 2025
  • NY State Medical License
    NY State Medical License 2016 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • eFFECTOR to Present Updated Clinical Data from Phase 2 Expansion Cohorts for Zotatifin in Patients with ER+ Metastatic Breast Cancer at ASCO 2023 Annual Meeting
    eFFECTOR to Present Updated Clinical Data from Phase 2 Expansion Cohorts for Zotatifin in Patients with ER+ Metastatic Breast Cancer at ASCO 2023 Annual MeetingApril 26th, 2023
  • SpringWorks Therapeutics Announces Phase 1b/2a Clinical Trial of Mirdametinib in Patients with Advanced Solid Cancers Harboring MAPK-Activating Mutations
    SpringWorks Therapeutics Announces Phase 1b/2a Clinical Trial of Mirdametinib in Patients with Advanced Solid Cancers Harboring MAPK-Activating MutationsAugust 3rd, 2021
  • Zotatifin Triplet May Improve Outcomes Post–CDK4/6 Inhibition in ER+ Breast Cancer
    Zotatifin Triplet May Improve Outcomes Post–CDK4/6 Inhibition in ER+ Breast CancerOctober 20th, 2023

Hospital Affiliations